Related references
Note: Only part of the references are listed.The regulation of aldosterone secretion by leptin: implications in obesity-related cardiovascular disease
Jessica L. Faulkner et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
Low- and High-renin Heart Failure Phenotypes with Clinical Implications
Noemi Pavo et al.
CLINICAL CHEMISTRY (2018)
Effect of long-term treatment with melatonin on vascular markers of oxidative stress/inflammation and on the anticontractile activity of perivascular fat in aging mice
Claudia Agabiti-Rosei et al.
HYPERTENSION RESEARCH (2017)
Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial
Alberto Dominguez-Rodriguez et al.
JOURNAL OF PINEAL RESEARCH (2017)
Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1
Jianqiang Hu et al.
JOURNAL OF PINEAL RESEARCH (2017)
Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?
Ali Nehme et al.
HYPERTENSION RESEARCH (2017)
Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure
Xiaowei Zhang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril
Fedor Simko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
Ratnadeep Basu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Role of toll-like receptor 4 in melatonin-induced cardioprotection
Frederic Nduhirabandi et al.
JOURNAL OF PINEAL RESEARCH (2016)
New insights into the elucidation of angiotensin-(1-7) in vivo antiarrhythmic effects and its related cellular mechanisms
Julliane Vasconcelos Joviano-Santos et al.
EXPERIMENTAL PHYSIOLOGY (2016)
Estimation methods for human circadian phase by use of peripheral tissues
Ritsuko Matsumura et al.
HYPERTENSION RESEARCH (2016)
Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony
Alberto Dominguez-Rodriguez et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review
Fedor Simko et al.
JOURNAL OF PINEAL RESEARCH (2016)
Melatonin as an antioxidant: under promises but over delivers
Russel J. Reiter et al.
JOURNAL OF PINEAL RESEARCH (2016)
Melatonin: the dawning of a treatment for fibrosis?
Wei Hu et al.
JOURNAL OF PINEAL RESEARCH (2016)
The nuclear melatonin receptor ROR is a novel endogenous defender against myocardial ischemia/reperfusion injury
Ben He et al.
JOURNAL OF PINEAL RESEARCH (2016)
CSF generation by pineal gland results in a robust melatonin circadian rhythm in the third ventricle as an unique light/dark signal
Dun-Xian Tan et al.
MEDICAL HYPOTHESES (2016)
Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor
Lamei Yu et al.
PEPTIDES (2016)
Melatonin has multiorgan effects
Lionel H. Opie et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2016)
Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology
Jaroslav Hrenak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice
A. M. Papinska et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats
Takaichi Suehiro et al.
ENDOCRINOLOGY (2015)
Mechanisms of isoproterenol-induced cardiac mitochondrial damage: protective actions of melatonin
Debasri Mukherjee et al.
JOURNAL OF PINEAL RESEARCH (2015)
Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats
Sarah Sharp et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2015)
Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism
Dun-Xian Tan et al.
MOLECULES (2015)
Mineralocorticoid receptors in the heart: lessons from cell-selective transgenic animals
Morag J. Young et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Extrapineal melatonin: sources, regulation, and potential functions
Dario Acuna-Castroviejo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Peripheral and Central Effects of Melatonin on Blood Pressure Regulation
Olga Pechanova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure
Fedor Simko et al.
JOURNAL OF PINEAL RESEARCH (2014)
Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets
Fan Jiang et al.
NATURE REVIEWS CARDIOLOGY (2014)
Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin
Fedor Simko et al.
MEDIATORS OF INFLAMMATION (2014)
Experimental models of melatonin-deficient hypertension
Fedor Simko et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2013)
Antifibrotic effect of melatonin-Perspective protection in hypertensive heart disease
Fedor Simko et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Chronobiology of blood pressure: emerging implications of melatonin
Fedor Simko
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Cardiac autonomic function in acutely nitric oxide deficient hypertensive rats: role of the sympathetic nervous system and oxidative stress
Meenakshi Chaswal et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2011)
Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment
Ludovit Paulis et al.
JOURNAL OF HYPERTENSION (2010)
Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril
Fedor Simko et al.
JOURNAL OF HYPERTENSION (2010)
Remodelling of the heart and vessels in experimental hypertension: advances in protection Introduction
Fedor Simko et al.
JOURNAL OF HYPERTENSION (2010)
Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin
Russel J. Reiter et al.
JOURNAL OF HYPERTENSION (2010)
Melatonin interactions with blood pressure and vascular function during L-NAME-induced hypertension
Ludovit Paulis et al.
JOURNAL OF PINEAL RESEARCH (2010)
Novel therapeutic targets for hypertension
Ludovit Paulis et al.
NATURE REVIEWS CARDIOLOGY (2010)
Recent trends in hypertension treatment: perspectives from animal studies Introduction
Fedor Simko et al.
JOURNAL OF HYPERTENSION (2009)
Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats
Ludovit Paulis et al.
JOURNAL OF HYPERTENSION (2009)
Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats
Fedor Simko et al.
JOURNAL OF HYPERTENSION (2009)
Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment
Fedor Simko et al.
JOURNAL OF PINEAL RESEARCH (2009)
Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats
Hirofumi Ikeda et al.
KIDNEY INTERNATIONAL (2009)
Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation
Morag J. Young
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2008)
The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension
Olga Pechanova et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Melatonin as a potential antihypertensive treatment
Fedor Simko et al.
JOURNAL OF PINEAL RESEARCH (2007)
Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME
IF Benter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Mechanisms of mineralocorticoid action
PJ Fuller et al.
HYPERTENSION (2005)
L-Arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension
F Simko et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension
F Simko et al.
LIFE SCIENCES (2004)
Treatment by N-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve
H Girouard et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells
K Nithipatikom et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
NO synthase inhibition increases aldosterone in humans
JAS Muldowney et al.
HYPERTENSION (2004)
Effects of nitric oxide on aldosterone synthesis and nitric oxide synthase activity in glomerulosa cells from bovine adrenal gland
JM Sainz et al.
ENDOCRINE (2004)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Stimulation of endogenous nitric oxide production is involved in the inhibitory effect of adrenomedullin on aldosterone secretion in the rat
P Rebuffat et al.
PEPTIDES (2001)
Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy:: Effect of captopril
I Bernatova et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
